Kevan Oconnor | Venture Investor
Cystic Fibrosis Foundation
Kevan is a life sciences business development and investments professional, and leads infectious disease investments at the CFF. Passionate about partnerships, creativeity, and value creation in the AMR space.
Appearances:
Day 1- World Orphan Drug Congress USA 2025 @ 15:50
Panel: Funding futures: Evaluating investment potential in rare disease and orphan drug markets
In this session, we will evaluate the investment potential within the rare disease and orphan drug markets, exploring the unique opportunities and challenges these sectors present. Attendees will gain insights into the growing demand for innovative treatments for underserved patient populations and the financial implications of developing therapies for rare conditions. We will also discuss the regulatory landscape, funding trends, and key factors influencing investment decisions. By examining the current investment climate and forecasting future trends, this session aims to provide a comprehensive understanding of how to navigate and capitalize on the evolving rare disease and orphan drug landscape.
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events